Cargando…
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agents
Despite advances in the development of clinical agents for treating Mantle Cell Lymphoma (MCL), treatment of MCL remains a challenge due to complexity and frequent relapse associated with MCL. The incorporation of conventional and novel diagnostic approaches such as genomic sequencing have helped im...
Autores principales: | Inamdar, Arati A., Goy, Andre, Ayoub, Nehad M., Attia, Christen, Oton, Lucia, Taruvai, Varun, Costales, Mark, Lin, Yu-Ting, Pecora, Andrew, Suh, Stephen K. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5217048/ https://www.ncbi.nlm.nih.gov/pubmed/27119356 http://dx.doi.org/10.18632/oncotarget.8961 |
Ejemplares similares
-
Biomarkers and novel therapeutic approaches for diffuse large B-cell lymphoma in the era of precision medicine
por: Lodhi, Niraj, et al.
Publicado: (2020) -
An Aggressive Presentation of Mantle Cell Lymphoma With Unique Molecular Features
por: Inamdar, Arati A, et al.
Publicado: (2021) -
Pediatric Hodgkin lymphoma– biomarkers, drugs, and clinical trials for translational science and medicine
por: Nagpal, Poonam, et al.
Publicado: (2016) -
Therapeutic antibodies for mantle cell lymphoma: A brand-new era ahead
por: Sun, Ming, et al.
Publicado: (2019) -
Left brachiocephalic vein vascular ring on CT: A rare venous anomaly
por: Taruvai, Varun, et al.
Publicado: (2022)